Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation for Cancer Treatment
N/A
N/A
Both
Neoplasms
Trial Information
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation for Cancer Treatment
The investigators have identified a combination of methods for possible cancer treatment as
follows:
1. Energy specific far infrared radiation (5 μm to 20 μm ). No x-rays, gamma rays etc.
are used.
2. Oxygenation of the body cells
3. pH balance
4. Lifestyle changes, or
5. A combination of chemotherapy and (1), (2), (3) and (4) above.
Inclusion Criteria:
- All cancer patients
Exclusion Criteria:
- non-cancer patients
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The effect of far infrared radiation on cancerous tumours
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Ken Nedd, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
GAAD Medical Research Institute Inc.
Authority:
Canada: Health Canada
Study ID:
GAAD-CAN-CTP1
NCT ID:
NCT00574106
Start Date:
February 2008
Completion Date:
October 2009
Related Keywords:
- Neoplasms
- Cancer
- Tumors
- Neoplasms
Name | Location |
|---|
